| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Unité de Pathogénie Microbienne Moléculaire, Institut National de la Santé et de la Recherche Médicale Unité 389;
Unité de Chimie Organique, Centre National de la Recherche Scientifique Unité de Recherche Associée 2128;
Plate-Forme 5, Production de Protéines Recombinantes et d’Anticorps; and
Unité d’Immunologie Structurale, Centre National de la Recherche Scientifique Unité de Recherche Associée 2185; Institut Pasteur, Paris, France
Protection against reinfection with noncapsulated Gram-negative bacteria, such as Shigella, an enteroinvasive bacterium responsible for bacillary dysentery, is mainly achieved by Abs specific for the O-Ag, the polysaccharide part of the LPS, the major bacterial surface Ag. The use of chemically defined glycoconjugates encompassing oligosaccharides mimicking the protective determinants carried by the O-Ag, thus expected to induce an efficient anti-LPS Ab response, has been considered an alternative to detoxified LPS-protein conjugate vaccines. The aim of this study was to identify such functional oligosaccharide mimics of the S. flexneri serotype 2a O-Ag. Using protective murine mAbs specific for S. flexneri serotype 2a and synthetic oligosaccharides designed to analyze the contribution of each sugar residue of the branched pentasaccharide repeating unit of the O-Ag, we demonstrated that the O-Ag exhibited an immunodominant serotype-specific determinant. We also showed that elongating the oligosaccharide sequence improved Ab recognition. From these antigenicity data, selected synthetic oligosaccharides were assessed for their potential to mimic the O-Ag by analyzing their immunogenicity in mice when coupled to tetanus toxoid via single point attachment. Our results demonstrated that induction of an efficient serotype 2a-specific anti-O-Ag Ab response was dependent on the length of the oligosaccharide sequence. A pentadecasaccharide representing three biological repeating units was identified as a potential candidate for further development of a chemically defined glycoconjugate vaccine against S. flexneri 2a infection.
This article has been cited by other articles:
|
|
 |
|
  B. Vulliez-Le Normand, F. A. Saul, A. Phalipon, F. Belot, C. Guerreiro, L. A. Mulard, and G. A. Bentley Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody PNAS, July 22, 2008; 105(29): 9976 - 9981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Borrelli, R. B. Hossany, and B. M. Pinto Immunological Evidence for Functional Rather than Structural Mimicry by a Shigella flexneri Y Polysaccharide-Mimetic Peptide Clin. Vaccine Immunol., July 1, 2008; 15(7): 1106 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chamekh, A. Phalipon, R. Quertainmont, I. Salmon, P. Sansonetti, and A. Allaoui Delivery of Biologically Active Anti-Inflammatory Cytokines IL-10 and IL-1ra In Vivo by the Shigella Type III Secretion Apparatus J. Immunol., March 15, 2008; 180(6): 4292 - 4298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Kadaoui and B. Corthesy Secretory IgA Mediates Bacterial Translocation to Dendritic Cells in Mouse Peyer's Patches with Restriction to Mucosal Compartment J. Immunol., December 1, 2007; 179(11): 7751 - 7757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Pozsgay, J. Kubler-Kielb, R. Schneerson, and J. B. Robbins Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice PNAS, September 4, 2007; 104(36): 14478 - 14482. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
